{'fraction_non_alphanumeric': 0.01897810218978102, 'fraction_numerical': 0.008759124087591242, 'mean_word_length': 5.792079207920792, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Comparative Investigation on the Activity of a Synthetic Corticotrophin (18-ACTH). A Clinical Trial

The effect of the administration of a synthetic peptide with corticotrophic properties (18-ACTH) on the plasma corticosteroid levels of 72 healthy volunteers was studied. The same effect is seen both after subcutaneous and intramuscular injection. Intravenous administration provokes a longer lasting influence on adrenocortical activity, especially when large doses of the peptide are given; side effects however plead against this method of stimulation of the adrenal cortex. Discrepancies are reported between results from the fluorometric and radioimmuno assay of corticosteroids.